Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis.

Shu HK, Yoon Y, Hong S, Xu K, Gao H, Hao C, Torres-Gonzalez E, Nayra C, Rojas M, Shim H.

PLoS One. 2013 Nov 7;8(11):e79768. doi: 10.1371/journal.pone.0079768. eCollection 2013.

2.

Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.

Song JS, Kang CM, Kang HH, Yoon HK, Kim YK, Kim KH, Moon HS, Park SH.

Exp Mol Med. 2010 Jun 30;42(6):465-72.

3.

Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis.

Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M.

Am J Respir Cell Mol Biol. 2007 Sep;37(3):291-9. Epub 2007 Apr 26.

4.

Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.

Michineau S, Franck G, Wagner-Ballon O, Dai J, Allaire E, Gervais M.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1747-55. doi: 10.1161/ATVBAHA.114.303913. Epub 2014 May 29.

5.

Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.

Makino H, Aono Y, Azuma M, Kishi M, Yokota Y, Kinoshita K, Takezaki A, Kishi J, Kawano H, Ogawa H, Uehara H, Izumi K, Sone S, Nishioka Y.

J Med Invest. 2013;60(1-2):127-37.

6.

Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.

Kawaguchi A, Orba Y, Kimura T, Iha H, Ogata M, Tsuji T, Ainai A, Sata T, Okamoto T, Hall WW, Sawa H, Hasegawa H.

Blood. 2009 Oct 1;114(14):2961-8. doi: 10.1182/blood-2008-11-189308. Epub 2009 Aug 5.

7.

Development of a unique small molecule modulator of CXCR4.

Liang Z, Zhan W, Zhu A, Yoon Y, Lin S, Sasaki M, Klapproth JM, Yang H, Grossniklaus HE, Xu J, Rojas M, Voll RJ, Goodman MM, Arrendale RF, Liu J, Yun CC, Snyder JP, Liotta DC, Shim H.

PLoS One. 2012;7(4):e34038. doi: 10.1371/journal.pone.0034038. Epub 2012 Apr 2.

8.

The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.

Yoshida D, Koketshu K, Nomura R, Teramoto A.

J Neurooncol. 2010 Oct;100(1):51-64. doi: 10.1007/s11060-010-0152-6. Epub 2010 Mar 23.

PMID:
20309720
9.

Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment.

Garibaldi BT, D'Alessio FR, Mock JR, Files DC, Chau E, Eto Y, Drummond MB, Aggarwal NR, Sidhaye V, King LS.

Am J Respir Cell Mol Biol. 2013 Jan;48(1):35-43. doi: 10.1165/rcmb.2012-0198OC. Epub 2012 Sep 20.

10.

Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.

Theiss HD, Vallaster M, Rischpler C, Krieg L, Zaruba MM, Brunner S, Vanchev Y, Fischer R, Gröbner M, Huber B, Wollenweber T, Assmann G, Mueller-Hoecker J, Hacker M, Franz WM.

Stem Cell Res. 2011 Nov;7(3):244-55. doi: 10.1016/j.scr.2011.05.003. Epub 2011 May 16.

PMID:
21752744
11.

Dual effect of AMD3100, a CXCR4 antagonist, on bleomycin-induced lung inflammation.

Watanabe M, Matsuyama W, Shirahama Y, Mitsuyama H, Oonakahara K, Noma S, Higashimoto I, Osame M, Arimura K.

J Immunol. 2007 May 1;178(9):5888-98. Retraction in: Watanabe M, Shirahama Y, Mitsuyama H, Oonakahara K, Noma S, Higashimoto I, Osame M, Arimura K. J Immunol. 2008 Nov 1;181(9):6670.

12.

Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.

Ray P, Lewin SA, Mihalko LA, Schmidt BT, Luker KE, Luker GD.

Neoplasia. 2011 Dec;13(12):1152-61.

13.

Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension.

Young KC, Torres E, Hatzistergos KE, Hehre D, Suguihara C, Hare JM.

Circ Res. 2009 Jun 5;104(11):1293-301. doi: 10.1161/CIRCRESAHA.109.197533. Epub 2009 May 7.

14.

Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.

Mehrad B, Burdick MD, Strieter RM.

Int J Biochem Cell Biol. 2009 Aug-Sep;41(8-9):1708-18. doi: 10.1016/j.biocel.2009.02.020. Epub 2009 Mar 6.

15.

Expression of SDF-1/CXCR4 axis in bone marrow mesenchymal stem cells derived from rheumatoid arthritis-usual interstitial pneumonia.

Margaritopoulos GA, Antoniou KM, Lasithiotaki I, Proklou A, Soufla G, Siafakas NM.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4):610-1. Epub 2013 May 27.

PMID:
23710557
16.

Characterization of fibroblasts recruited from bone marrow-derived precursor in neonatal bronchopulmonary dysplasia mice.

Deng C, Wang J, Zou Y, Zhao Q, Feng J, Fu Z, Guo C.

J Appl Physiol (1985). 2011 Jul;111(1):285-94. doi: 10.1152/japplphysiol.00201.2010. Epub 2011 Jan 13.

17.

SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition.

Liu X, Zhou C, Li Y, Ji Y, Xu G, Wang X, Yan J.

PLoS One. 2013;8(1):e54077. doi: 10.1371/journal.pone.0054077. Epub 2013 Jan 22.

18.

CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2.

Ghosh MC, Makena PS, Gorantla V, Sinclair SE, Waters CM.

Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L846-56. doi: 10.​1152/​ajplung.​00321.​2011. Epub 2012 Feb 17.

19.

Stromal cell-derived factor-1 receptor CXCR4-overexpressing bone marrow mesenchymal stem cells accelerate wound healing by migrating into skin injury areas.

Yang D, Sun S, Wang Z, Zhu P, Yang Z, Zhang B.

Cell Reprogram. 2013 Jun;15(3):206-15. doi: 10.1089/cell.2012.0046.

20.

Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.

Chen W, Li M, Cheng H, Yan Z, Cao J, Pan B, Sang W, Wu Q, Zeng L, Li Z, Xu K.

Cell Biochem Biophys. 2013;67(3):1181-91. doi: 10.1007/s12013-013-9632-6.

PMID:
23712865
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk